Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachna T Shroff

Showing results (11-20 of 76) with videos related to

Pageof 8
Sort By:
Lancet (London, England)|June 29, 2020
Pancreatic cancerJonathan D Mizrahi, Rishi Surana, Juan W Valle, et al.
BMC Cancer|November 17, 2022
Epidemiologic patterns of biliary tract cancer in the United States: 2001-2015Jill Koshiol, Binbing Yu, Shaum M Kabadi, et al.
Surgery|July 4, 2015
Underuse of surgical resection among elderly patients with early-stage pancreatic cancerWeiguo He, Hui Zhao, Wenyaw Chan, et al.
World Journal of Gastrointestinal Oncology|January 23, 2020
Multi-institutional retrospective analysis of FOLFIRI in patients with advanced biliary tract cancersJonathan D Mizrahi, Valerie Gunchick, Kabir Mody, et al.
Hepatology Communications|June 9, 2025
Intrahepatic cholangiocarcinoma: Insights on molecular testing, targeted therapies, and future directions from a multidisciplinary panelRushabh Gujarathi, Supriya Peshin, Xuchen Zhang, et al.
Journal of Gastrointestinal Oncology|December 2, 2014
Second-line systemic treatment for advanced cholangiocarcinomaJane E Rogers, Lindsey Law, Van D Nguyen, et al.
Journal of Gastrointestinal Oncology|August 27, 2016
BRCA-associated protein 1 mutant cholangiocarcinoma: an aggressive disease subtypeHumaid O Al-Shamsi, Deepa Anand, Rachna T Shroff, et al.
Journal of Gastrointestinal Oncology|May 9, 2017
Systemic therapy for unresectable, mixed hepatocellular-cholangiocarcinoma: treatment of a rare malignancyJane E Rogers, Ryan M Bolonesi, Asif Rashid, et al.
Journal of Gastrointestinal Oncology|March 17, 2020
Dose-modified gemcitabine plus nab-paclitaxel front-line in advanced pancreatic ductal adenocarcinoma with baseline hyperbilirubinemiaJane E Rogers, Jonathan D Mizrahi, Rachna T Shroff, et al.
World Journal of Gastrointestinal Oncology|October 31, 2019
Evaluation of the safety and effectiveness of direct oral anticoagulants and low molecular weight heparin in gastrointestinal cancer-associated venous thromboembolismAlejandro Recio-Boiles, Sumana Veeravelli, Jessica Vondrak, et al.
Pageof 8

Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
Lancet (London, England)|June 29, 2020
Pancreatic cancerJonathan D Mizrahi, Rishi Surana, Juan W Valle, et al.
BMC Cancer|November 17, 2022
Epidemiologic patterns of biliary tract cancer in the United States: 2001-2015Jill Koshiol, Binbing Yu, Shaum M Kabadi, et al.
Surgery|July 4, 2015
Underuse of surgical resection among elderly patients with early-stage pancreatic cancerWeiguo He, Hui Zhao, Wenyaw Chan, et al.
World Journal of Gastrointestinal Oncology|January 23, 2020
Multi-institutional retrospective analysis of FOLFIRI in patients with advanced biliary tract cancersJonathan D Mizrahi, Valerie Gunchick, Kabir Mody, et al.
Hepatology Communications|June 9, 2025
Intrahepatic cholangiocarcinoma: Insights on molecular testing, targeted therapies, and future directions from a multidisciplinary panelRushabh Gujarathi, Supriya Peshin, Xuchen Zhang, et al.
Journal of Gastrointestinal Oncology|December 2, 2014
Second-line systemic treatment for advanced cholangiocarcinomaJane E Rogers, Lindsey Law, Van D Nguyen, et al.
Journal of Gastrointestinal Oncology|August 27, 2016
BRCA-associated protein 1 mutant cholangiocarcinoma: an aggressive disease subtypeHumaid O Al-Shamsi, Deepa Anand, Rachna T Shroff, et al.
Journal of Gastrointestinal Oncology|May 9, 2017
Systemic therapy for unresectable, mixed hepatocellular-cholangiocarcinoma: treatment of a rare malignancyJane E Rogers, Ryan M Bolonesi, Asif Rashid, et al.
Journal of Gastrointestinal Oncology|March 17, 2020
Dose-modified gemcitabine plus nab-paclitaxel front-line in advanced pancreatic ductal adenocarcinoma with baseline hyperbilirubinemiaJane E Rogers, Jonathan D Mizrahi, Rachna T Shroff, et al.
World Journal of Gastrointestinal Oncology|October 31, 2019
Evaluation of the safety and effectiveness of direct oral anticoagulants and low molecular weight heparin in gastrointestinal cancer-associated venous thromboembolismAlejandro Recio-Boiles, Sumana Veeravelli, Jessica Vondrak, et al.
Pageof 8